Description
Buy Authentic PT-141 10mg Online
PT-141 10mg is a research-use-only laboratory material supplied for controlled research workflows, compound characterization, and analytical documentation review. It is manufactured under rigorous quality standards to support consistency, traceability, and batch-specific verification for qualified laboratory settings.
What PT-141 10mg is
PT-141, also called bremelanotide, is a synthetic peptide analog of alpha-MSH. It’s a cyclic heptapeptide that was originally derived from Melanotan II research. The “10mg” is the amount of lyophilized powder per vial. It’s sold strictly as a research peptide for laboratory studies, not for human or veterinary use outside of approved drugs.
Key Product Details of PT-141 10mg
- Manufactured in accordance with rigorous quality standards to support ≥99% purity, as reflected in batch-specific documentation where available.
- Every batch is third-party analyzed for identity, assay/potency, and sterility documentation where applicable.
- Supplied in lyophilized powder form to help preserve stability throughout transport and storage.
- Produced with lot-level traceability to support research documentation and laboratory recordkeeping.
Research Documentation Context
- Supports compound characterization in controlled laboratory settings.
- Provides batch-specific identity and purity documentation for research review.
- Allows lot-level traceability across laboratory documentation workflows.
- Supports comparison of product labeling, analytical documentation, and storage information during research planning.
- Supports analytical review of receptor-pathway research materials within a strictly laboratory-focused context.
Specifications and Documentation
- Certificate of Analysis: Available with batch-specific documentation where applicable.
- Product Form: Lyophilized powder.
- Purity Specification: ≥99% purity.
- Intended Use: Laboratory research use only.
PT-141 10mg is intended strictly for laboratory research use only. This product is not intended for human or animal consumption, therapeutic use, diagnostic use, clinical use, veterinary use, or as a food, drug, cosmetic, dietary supplement, or household product.
How researchers study it
In preclinical models, PT-141 is used to investigate melanocortin receptors, specifically MC3R and MC4R in the central nervous system. Unlike PDE5 inhibitors that act on blood flow, PT-141 works through CNS pathways in the hypothalamus that influence sexual arousal and response. Labs use it to study neurotransmitter signaling related to sexual function in animal models.
Why it gets research attention
PT-141 came out of research into Melanotan II’s unintended side effects on arousal. Researchers isolated that effect and developed bremelanotide to study central mechanisms of sexual function, separate from vascular pathways. A drug version, Vyleesi, was FDA-approved in 2019 for premenopausal women with hypoactive sexual desire disorder. The research chemical PT-141 is not that approved drug product.
Form, purity & handling
PT-141 10mg is typically supplied as a white, freeze-dried powder in a sealed sterile vial. Reputable suppliers include a Certificate of Analysis with HPLC and mass spec to verify sequence and purity, usually >95% for research grade. Peptides degrade with heat, light, and moisture, so it’s shipped cold and stored at -20°C or -80°C after reconstitution.
Legal + safety status
The research chemical PT-141 is not FDA-approved for human use. It’s classified “for research use only, not for human consumption.” The FDA-approved drug bremelanotide/Vyleesi is a prescription product with controlled dosing, safety data, and medical oversight. The 10mg research vial has no established human dose, safety profile, or pharmaceutical manufacturing standards. It’s also banned by WADA for athletes.
Bottom line
*PT-141 10mg* is a research tool used to study melanocortin receptors and CNS pathways related to arousal in the lab. While bremelanotide is an approved medication, the research chemical version is not equivalent — it lacks clinical oversight, dosing guidelines, and safety data for people. For sexual health concerns, talk to a licensed healthcare provider about FDA-approved options and evidence-based care.
